| 摘要 |
FIELD: ophthalmology. SUBSTANCE: invention is distinguished by that known ocular drops containing sodium succinate hexahydrate (1.351 wt %), benzalkonium chloride (0.015%), and distilled water (the balance), additionally contain sodium pyruvate (0.550), riboflavin mononucleotide phosphate (0.002%), and thiamine hydrochloride (0.020%). In one of the versions of invention, ocular drops additionally contain fructose and glucose in quantities 0.100 and 0.300 g/100 ml, respectively. EFFECT: extended choice of therapeutic means. 2 cl, 4 ex
|
